CD4 and myeloid sarcoma: Similarly, CD4+ iNKT cells were previously observed to be skewed towards Th2-type response, in terms of cytokine production, in MS compared to HC, in the same time the CD4− iNKT subsets revealed neither Th1- nor Th2- predominance [26].